Association Between Neuromuscular Parameters and Functional Assessment After ACL Reconstruction

ConditionACL Injury
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-40
SponsorUniversity Hospital, Caen

About this trial

The anterior cruciate ligament (ACL) injury is common in athletes aged 18 to 35. ACL reconstruction (ACLR) aims to restore knee stability in the process of returning to sports. Post-surgical rehabilitation focuses on optimizing biomechanical parameters, with neuromuscular and functional tests assessing muscle strength, proprioception, and dynamic stability. Isokinetic allows the measurement of muscle strength symmetry and proprioception, while the single-leg hop and landing tasks assess functional stability and are predictive of sports resumption and injury prevention. Despite progress, concerns remain about neuromuscular factors impacting knee stability, especially during landings, which can increase the risk of secondary ACL injuries.

This study proposes examining knee strength and proprioception using isokinetic dynamometry, alongside biomechanical assessments from functional tests, to explore their relationship to biomechanical features during landings, at 6-to-12 months post-ACL reconstruction. The hypothesis is that better muscle strength and proprioception correlate with improved knee control during landing tasks.

Eligibility criteria

Qualifiers

Adult patients, aged 18-40, who have undergone a first ACL reconstruction more than 6 months ago and are being followed in a sports medicine care pathway

Affiliated with a health insurance plan

Information form: Non-objection to the use of data for research purposes

Disqualifiers

Previous ligament surgery of the lower limbs prior to ACL reconstruction

Complex ligament injury (lateral ligaments, posterior cruciate ligament)

Recent muscle injuries

History of injury to the uninjured knee

Trial design

Treatments tested in this trial

  • Isokinetic neuromuscular assessment

Treatment groups

25 Participants
are divided into 1 treatment group

Locations

1
CHU Caen Normandie14000, Caen France

Sponsors and collaborators

University Hospital, Caen

Lead sponsor